Eton Pharmaceuticals (ETON) Depreciation & Amortization (CF) (2018 - 2025)

Eton Pharmaceuticals has disclosed Depreciation & Amortization (CF) across 8 years of filings, most recently posting $1.0 million for Q4 2025.

• In Q4 2025, Depreciation & Amortization (CF) rose 186.48% year-over-year to $1.0 million; the TTM figure through Jun 2026 stood at $3.0 million (up 14.33% YoY), while the FY2025 annual figure was $4.0 million, up 252.88% from the prior year.
• Depreciation & Amortization (CF) came in at $1.0 million for Q4 2025 at Eton Pharmaceuticals, up from $1.0 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.2 million in Q2 2022 to a low of $85000.0 in Q2 2021.
• Average Depreciation & Amortization (CF) over 5 years is $416350.0, with a median of $243000.0 recorded in 2022.
• Year-over-year, Depreciation & Amortization (CF) jumped 1277.65% in 2022 and sank 85.31% in 2023.
• Over 5 years, Depreciation & Amortization (CF) stood at $137000.0 in 2021, then soared by 83.94% to $252000.0 in 2022, then advanced by 28.97% to $325000.0 in 2023, then advanced by 9.23% to $355000.0 in 2024, then soared by 186.48% to $1.0 million in 2025.
• Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $1.0 million in Q4 2025, $1.0 million in Q3 2025, and $1.0 million in Q2 2025.